Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?
Abstract Introduction Currently, more than 4.5 billion doses of SARS-CoV-2 vaccines have been applied worldwide. However, some developing countries are still a long way from achieving herd immunity through vaccination. In some territories, such as the Colombian Amazon, mass immunization strategies h...
Published in: | Tropical Diseases, Travel Medicine and Vaccines |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
BMC
2022
|
Subjects: | |
Online Access: | https://doi.org/10.1186/s40794-021-00159-x https://doaj.org/article/6fd89f9e310943a8b1585da6232cf3c5 |
id |
ftdoajarticles:oai:doaj.org/article:6fd89f9e310943a8b1585da6232cf3c5 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:6fd89f9e310943a8b1585da6232cf3c5 2023-05-15T15:16:39+02:00 Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? Héctor Serrano-Coll Hollman Miller Camilo Guzmán Ricardo Rivero Bertha Gastelbondo Jorge Miranda Ketty Galeano Jhon Montaña-Restrepo Salim Mattar 2022-01-01T00:00:00Z https://doi.org/10.1186/s40794-021-00159-x https://doaj.org/article/6fd89f9e310943a8b1585da6232cf3c5 EN eng BMC https://doi.org/10.1186/s40794-021-00159-x https://doaj.org/toc/2055-0936 doi:10.1186/s40794-021-00159-x 2055-0936 https://doaj.org/article/6fd89f9e310943a8b1585da6232cf3c5 Tropical Diseases, Travel Medicine and Vaccines, Vol 8, Iss 1, Pp 1-6 (2022) COVID-19 vaccines Prevention Post-exposure Prophylaxis Public health Mass vaccination Arctic medicine. Tropical medicine RC955-962 article 2022 ftdoajarticles https://doi.org/10.1186/s40794-021-00159-x 2022-12-31T11:30:32Z Abstract Introduction Currently, more than 4.5 billion doses of SARS-CoV-2 vaccines have been applied worldwide. However, some developing countries are still a long way from achieving herd immunity through vaccination. In some territories, such as the Colombian Amazon, mass immunization strategies have been implemented with the CoronaVac® vaccine. Due to its proximity to Brazil, where one of the variants of interest of SARS-CoV-2 circulates. Objective To determine the effectiveness of the CoronaVac® vaccine in a population of the Colombian Amazon. Methods Between February 24, 2021, and August 10, 2021, a descriptive observational study was carried out in which a population of individuals over 18 years of age immunized with two doses of the CoronaVac® vaccine was evaluated. The study site was in the municipality of Mitú, Vaupés, in southeastern Colombia, a region located in the Amazon bordering Brazil. Results. 99% of the urban population of the Mitú municipality were vaccinated with CoronaVac®. To date, 5.7% of vaccinated individuals have become ill, and only 0.1% of these require hospitalization. One death was attributable to COVID-19 has been reported among vaccinated individuals, and the vaccine has shown 94.3% effectiveness against mild disease and 99.9% against severe infection. Conclusions The herd immunity achieved through mass vaccination in this population has made it possible to reduce the rate of complicated cases and mortality from COVID-19 in this region of the Colombian Amazon. Highlights CoronaVac® has shown 94.3% effectiveness against mild disease and 99.9% against severe infection in this indigenous population. CoronaVac® reduces the mortality rate from 2.2% in 2020 to 0.22% in 2021. The herd immunity was achieved through mass vaccination in this region of the Colombian Amazon. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Tropical Diseases, Travel Medicine and Vaccines 8 1 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English |
topic |
COVID-19 vaccines Prevention Post-exposure Prophylaxis Public health Mass vaccination Arctic medicine. Tropical medicine RC955-962 |
spellingShingle |
COVID-19 vaccines Prevention Post-exposure Prophylaxis Public health Mass vaccination Arctic medicine. Tropical medicine RC955-962 Héctor Serrano-Coll Hollman Miller Camilo Guzmán Ricardo Rivero Bertha Gastelbondo Jorge Miranda Ketty Galeano Jhon Montaña-Restrepo Salim Mattar Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? |
topic_facet |
COVID-19 vaccines Prevention Post-exposure Prophylaxis Public health Mass vaccination Arctic medicine. Tropical medicine RC955-962 |
description |
Abstract Introduction Currently, more than 4.5 billion doses of SARS-CoV-2 vaccines have been applied worldwide. However, some developing countries are still a long way from achieving herd immunity through vaccination. In some territories, such as the Colombian Amazon, mass immunization strategies have been implemented with the CoronaVac® vaccine. Due to its proximity to Brazil, where one of the variants of interest of SARS-CoV-2 circulates. Objective To determine the effectiveness of the CoronaVac® vaccine in a population of the Colombian Amazon. Methods Between February 24, 2021, and August 10, 2021, a descriptive observational study was carried out in which a population of individuals over 18 years of age immunized with two doses of the CoronaVac® vaccine was evaluated. The study site was in the municipality of Mitú, Vaupés, in southeastern Colombia, a region located in the Amazon bordering Brazil. Results. 99% of the urban population of the Mitú municipality were vaccinated with CoronaVac®. To date, 5.7% of vaccinated individuals have become ill, and only 0.1% of these require hospitalization. One death was attributable to COVID-19 has been reported among vaccinated individuals, and the vaccine has shown 94.3% effectiveness against mild disease and 99.9% against severe infection. Conclusions The herd immunity achieved through mass vaccination in this population has made it possible to reduce the rate of complicated cases and mortality from COVID-19 in this region of the Colombian Amazon. Highlights CoronaVac® has shown 94.3% effectiveness against mild disease and 99.9% against severe infection in this indigenous population. CoronaVac® reduces the mortality rate from 2.2% in 2020 to 0.22% in 2021. The herd immunity was achieved through mass vaccination in this region of the Colombian Amazon. |
format |
Article in Journal/Newspaper |
author |
Héctor Serrano-Coll Hollman Miller Camilo Guzmán Ricardo Rivero Bertha Gastelbondo Jorge Miranda Ketty Galeano Jhon Montaña-Restrepo Salim Mattar |
author_facet |
Héctor Serrano-Coll Hollman Miller Camilo Guzmán Ricardo Rivero Bertha Gastelbondo Jorge Miranda Ketty Galeano Jhon Montaña-Restrepo Salim Mattar |
author_sort |
Héctor Serrano-Coll |
title |
Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? |
title_short |
Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? |
title_full |
Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? |
title_fullStr |
Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? |
title_full_unstemmed |
Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? |
title_sort |
effectiveness of the coronavac® vaccine in a region of the colombian amazon, was herd immunity achieved? |
publisher |
BMC |
publishDate |
2022 |
url |
https://doi.org/10.1186/s40794-021-00159-x https://doaj.org/article/6fd89f9e310943a8b1585da6232cf3c5 |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Tropical Diseases, Travel Medicine and Vaccines, Vol 8, Iss 1, Pp 1-6 (2022) |
op_relation |
https://doi.org/10.1186/s40794-021-00159-x https://doaj.org/toc/2055-0936 doi:10.1186/s40794-021-00159-x 2055-0936 https://doaj.org/article/6fd89f9e310943a8b1585da6232cf3c5 |
op_doi |
https://doi.org/10.1186/s40794-021-00159-x |
container_title |
Tropical Diseases, Travel Medicine and Vaccines |
container_volume |
8 |
container_issue |
1 |
_version_ |
1766346950891798528 |